RxDoctor Payments Data

Johan Aasbo, DO

Clinical Cardiac Electrophysiology · Lexington, KYNPI 1396820213

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $391,163 of the $450,929 with a category attached, or 86.7%. Boston Scientific accounts for 90.5% of it on its own, with 30 other manufacturers making up the rest. 2025 is the largest year on record at $276,562, more than ten times the $19,909 reported in 2019. Among clinical cardiac electrophysiology clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$450,929in general payments, 2019–2025

Across 671 payments — averaging $672.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$408K
  • Biotronik Inc.$18K
  • ZOLL Respicardia, Inc.$9K
  • Abbott$4K
  • Impulse Dynamics (USA) Inc.$4K
  • Acutus Medical, Inc.$2K
  • plus $7K from 25 others
$364,253in research payments, 2019–2025

Across 236 payments — averaging $1543.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$255K
  • ZOLL Respicardia, Inc.$71K
  • Biotronik Inc.$38K

What the payments were for

  • Consulting fees$13,8563%
  • Speaking & faculty fees$391,16387%
  • Travel & lodging$25,5056%
  • Food & beverage$20,3805%
  • Entertainment$260%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$450,929 in reported general payments places this provider in the 95th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.

See all clinical cardiac electrophysiology providers in Kentucky

Medicare billing

Part B allowed, 2024
$313,120
Medicare patients
1,039
Services billed
4,047

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban430$437,802
XareltoRivaroxaban106$121,752
EntrestoSacubitril/Valsartan39$32,588
MultaqDronedarone Hcl25$29,344
Flecainide Acetate133$10,385
JardianceEmpagliflozin14$8,450
Dabigatran EtexilateDabigatran Etexilate Mesylate15$4,195
Dofetilide35$3,617
Diltiazem 24hr Er (Cd)Diltiazem Hcl50$2,282
Amiodarone Hcl34$1,983
Mexiletine Hcl13$1,847
Metoprolol Succinate124$1,384
SotalolSotalol Hcl77$1,341
Propranolol Hcl ErPropranolol Hcl13$561
ClopidogrelClopidogrel Bisulfate74$501

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$65$437,802430 claims
Johnson & JohnsonXarelto$13$121,752106 claims
NovartisEntresto$40$32,58839 claims
Sanofi-aventis U.S. LLCMultaq$36$29,34425 claims
Boehringer IngelheimJardiance$12$8,45014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.

Other clinical cardiac electrophysiology in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →